The aTIV vaccine provides better protection against influenza-related medical encounters than the HD-TIV vaccine in high-risk older adults.

The FDA has approved at-home self- or caregiver-administration of FluMist (influenza vaccine live, intranasal).

The US Food and Drug Administration on Friday approved the first flu vaccine that does not have to be administered by a ...

The U.S. Food and Drug Administration has approved FluMist — the nasal spray flu vaccine — for home use by a patient or adult ...

The WHO recommends manufacturers produce trivalent (three-strain) vaccines for use in the 2025 Southern Hemisphere influenza ...

People could previously get the nasal spray flu vaccine, called FluMist, from a health care provider, but now they can ...

The Food and Drug Administration announced Friday it had broadened the approval of the FluMist nasal spray to become the ...

· FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider. · FluMist ...

On September 20, 2024, the U.S. Food & Drug Administration (FDA) announced they had approved an at-home nasal spray influenza ...

AstraZeneca has a new at-home flu vaccine coming out. When will it arrive and how will it be administered? Here's what to ...

FluMist Home, like the original version administered in medical offices and pharmacies, is for adults under age 50 and kids 2 ...

Next year’s flu season will have an additional option for people looking to protect themselves: a flu vaccine that can be ...